Goals of dyslipidemia management: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 5, 2007, Pages 209-212

  Teramoto, Tamio ^a   Sasaki, Jun ^a   Ueshima, Hirotsugu ^a   Egusa, Genshi ^a   Kinoshita, Makoto ^a   Shimamoto, Kazuaki ^a   Daida, Hiroyuki ^a   Biro, Sadatoshi ^a   Hirobe, Kazuhiko ^a   Funahashi, Tohru ^a   Yokote, Koutaro ^a   Yokode, Masayuki ^a  

^a Committee for Epidemiology and Clinical Management of Atherosclerosis ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

BLOOD; CLASSIFICATION; DYSLIPIDEMIA; HUMAN; REVIEW; RISK FACTOR;

CHOLESTEROL; DYSLIPIDEMIAS; HUMANS; RISK FACTORS;

EID: 38449106666     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E554     Document Type: Article

References (16)

1. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S). Lancet, 1994; 344:1383-1389
2. Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 1996; 335:1001-1009
3. The Long-Term Intervention with Pravastatin in Ischaemic Disease(LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998; 339:1349-1357
4. Sakamoto T, Kojima S, Ogawa H, et al: Multicenter Study for Aggressive Lipid-Lowering Strategy by HMG-CoA Reductase Inhibitors in patients With Acute Myocardial Infarction(MUASASHI-AMI) Investigators: Effects of early statin treatment on symptomatic heart failure and ischemic events aher acute myocardial infarction in Japanese. Am J Cardiol, 2006; 97:1165-1171
5. Okazaki S, Takayuki Y, Miyauchi K, et al: Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation, 2004; 110:1061-1068
6. Okamura T, Tanaka H, Miyamatsu N, et al; for the NIPPON DATA80 research group: The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis, 2007; 190:216-223
7. Okamura T, Kadowaki K, Hayakawa T; for the NIPPON DATA80 research group: What cause of mortality can we predict by cholesterol screening in the Japanese general population? Int J Med, 2003; 253:169-180
8. Okamura T, Hayakawa T, Kadowaki T, et al; NIPPON DATA80 research group. A combination of serum low albumin and above-average cholesterol level was associated with excess mortality. J Clin Epidemiol, 2004; 57:1188-1195
9. Nakamura Y, Okamura T, Tamaki S, et al; NIPPON DATA80 Research Group: Egg consumption, serum cholesterol, and cause-specific and all-cause mortality: the National Integrated Project for Prospective Observation of Non-communicable Disease and Its Trends in the Aged, 1980 (NIPPON DATA80). Am J Clin Nutr, 2004; 80:58-63
10. Marsuzaki M, Kita T, Mabuchi H, et al; J-LIT Study Group. Japan Lipid Intervention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J, 2002; 66:1087-1095
11. Matsuzawa Y, Kita T, Mabuchi H, et al; J-LIT Study Group: Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. Circ J, 2003; 67:287-294
12. Horiuchi H, Kita T, Mabuchi H, et al; J-LIT Study Group: Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: A subanalysis of the Japan Lipid Intervention Trial. J Am Geriatr Soc, 2004; 52:1981-1987
13. Sone H, Tanaka S, Ishibashi S, Yamasaki Y. Oikawa S, Ito H, Saito Y, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study (JDCS) Group. The new world-wide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care, 2006; 29:145-147
14. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998; 352:837-853
15. Baigent C, Keech A, Kearney PM, et al: Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366:1267-1278
16. Grundy SM, Cleeman JI, Metz CN, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 2004; 110:227-239